# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-056713
Filing Date
2026-05-07
Accepted
2026-05-07 08:09:48
Documents
55
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ewtx-20260331x10q.htm iXBRL | 10-Q | 1696877
2 | EX-10.1 | ewtx-20260331xex10d1.htm | EX-10.1 | 67589
3 | EX-31.1 | ewtx-20260331xex31d1.htm | EX-31.1 | 19509
4 | EX-31.2 | ewtx-20260331xex31d2.htm | EX-31.2 | 19295
5 | EX-32.1 | ewtx-20260331xex32d1.htm | EX-32.1 | 7464
6 | EX-32.2 | ewtx-20260331xex32d2.htm | EX-32.2 | 7496
| Complete submission text file | 0001104659-26-056713.txt |  | 5402651

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | EX-101.SCH | ewtx-20260331.xsd | EX-101.SCH | 27697
8 | EX-101.CAL | ewtx-20260331_cal.xml | EX-101.CAL | 30807
9 | EX-101.DEF | ewtx-20260331_def.xml | EX-101.DEF | 116033
10 | EX-101.LAB | ewtx-20260331_lab.xml | EX-101.LAB | 264794
11 | EX-101.PRE | ewtx-20260331_pre.xml | EX-101.PRE | 208298
59 | EXTRACTED XBRL INSTANCE DOCUMENT | ewtx-20260331x10q_htm.xml | XML | 729664

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 26950976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)